Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.46 |
| ▸ | CTSG | P08311 | 2/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | TSLP | Q969D9 | 5/20 | 0.42 |
| ▸ | PLAU | P00749 | 2/20 | 0.42 |
| ▸ | TNFSF11 | O14788 | 1/20 | 0.42 |
| ▸ | NPR1 | P16066 | 1/20 | 0.41 |
| ▸ | NPR3 | P17342 | 1/20 | 0.41 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.41 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.41 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.41 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.41 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.40 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.40 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.40 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.40 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13662751 | 0.88 | SSTR1 (0.49) | ALBCTSGKEAP1NFE2L2TSLP | |
| SCHEMBL13659880 | 0.85 | ITGB3 (0.50) | ALBCTSGTSLPPLAUITGB3 | |
| SCHEMBL16298642 | 0.83 | ALB (0.47) | ALBCTSGTSLPPLAUTNFSF11 | |
| SCHEMBL16298632 | 0.82 | ITGB3 (0.49) | ALBCTSGTSLPPLAUITGB3 | |
| SCHEMBL13870381 | 0.81 | ITGB3 (0.56) | ALBCTSGKEAP1NFE2L2TSLP | |
| SCHEMBL13748443 | 0.81 | ITGB3 (0.56) | ALBCTSGKEAP1NFE2L2TSLP | |
| SCHEMBL12353644 | 0.81 | ITGB3 (0.51) | ALBCTSGKEAP1NFE2L2TSLP | |
| SCHEMBL13748431 | 0.81 | ITGB3 (0.56) | ALBCTSGKEAP1NFE2L2TSLP | |
| SCHEMBL12353684 | 0.81 | ITGB3 (0.50) | ALBCTSGKEAP1NFE2L2TSLP | |
| Maraciclatide SCHEMBL29408682 | 0.81 | ITGB3 (0.55) | ALBCTSGKEAP1NFE2L2TSLP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8361443-B2 | Peptide-based compounds | GE HEALTHCARE AS (NO) | 2013-01-29 | — | — | US | disclosed |
| US-20090263320-A1 | Peptide-Based Compounds | GE HEALTHCARE AS (NO) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263320-A1 | Peptide-Based Compounds | ITGB3, ITGAV, SELPLG | ALB 4118/4885CTSG 920/4885KEAP1 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.